![]() |
市場調査レポート
商品コード
1363071
ミクロトームの市場規模、シェア、動向分析レポート:製品別、技術別、地域別、セグメント予測、2023年~2030年Microtome Market Size, Share & Trends Analysis Report By Product (Microtome Devices, Accessories), By Technology (Fully Automated, Manual), By Region, And Segment Forecasts, 2023 - 2030 |
||||||
カスタマイズ可能
|
ミクロトームの市場規模、シェア、動向分析レポート:製品別、技術別、地域別、セグメント予測、2023年~2030年 |
出版日: 2023年09月18日
発行: Grand View Research
ページ情報: 英文 106 Pages
納期: 2~10営業日
|
Grand View Research, Inc.の最新レポートによると、ミクロトームの世界市場規模は2023年から2030年にかけてCAGR 6.4%を記録し、2030年には2億3,300万米ドルに達すると予測されています。
慢性疾患の早期診断に対する意識の高まりや、技術的に高度な診断機器に対する需要の増加は、市場を牽引すると予想される主要因の一部です。
Laboratory Economics社の推計によると、2012年には1996年から2011年の間に200億米ドル以上が検査室の合併に費やされました。2011年には、約35億米ドルが検査室合併に費やされました。世界の高齢者人口の増加、ヘルスケア支出の増加、早期疾病診断に関する患者の意識の高まりは、組織診断市場を促進すると予想される主な要因の一部です。その結果、組織スライシング装置の需要も増加すると思われます。しかし、診療報酬の削減や病院の統廃合は成長の妨げになると予想される要因の一つです。
米国は一人当たりのヘルスケア支出では第一位であるが、臨床検査室への支出は他のヘルスケアに比べ著しく低いです。さらに、臨床検査市場の全体的な成長は、人口統計学的要因、技術的・医学的・科学的進歩、その地域特有の疾病負担に大きく左右されます。米国、ドイツ、日本、カナダ、フランスなどの先進経済諸国は、新興経済諸国と比較して、莫大な研究開発予算、高い技術進歩、様々な健康面に関する意識の高さを持っています。このため、これらの地域ではシェアの大半を占めると思われます。
病理組織検査室数の成長、新興国における解剖学的病理検査室の高い成長性、デジタル病理システムに関する意識の高まりは、プレーヤーに新たな機会を提供できる主要な属性です。がんやその他の感染症など、さまざまな疾患の診断において、技術的に高度なバイオマーカーの利用が拡大していることから、組織検査機器の普及率は大幅に上昇すると予想されます。
List of Figure
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Microtome: market outlook
Fig. 9 Microtome competitive insights
Fig. 10 Parent market outlook
Fig. 11 Related/ancillary market outlook
Fig. 12 Penetration and growth prospect mapping
Fig. 13 Industry value chain analysis
Fig. 14 Microtome market driver impact
Fig. 15 Microtome market restraint impact
Fig. 16 Microtome market strategic initiatives analysis
Fig. 17 Microtome market: Product movement analysis
Fig. 18 Microtome market: Product outlook and key takeaways
Fig. 19 Microtome devices market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 20 Rotary microtome market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 21 Vibrating microtome market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 22 Other microtome market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 23 Accessories market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 24 Microtome market: Technology movement analysis
Fig. 25 Microtome market: Technology outlook and key takeaways
Fig. 26 Fully automated market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 27 Semi-automated market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 28 Manual market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 29 Global microtome market: Regional movement analysis
Fig. 30 Global microtome market: Regional outlook and key takeaways
Fig. 31 North America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 32 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 34 Europe. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 U.K. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 France market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 38 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 39 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 40 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 41 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 42 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 44 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 45 China market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 46 India market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 47 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 49 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 51 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 53 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 56 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 58 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
The global microtome market size is expected to reach USD 233.0 million by 2030, registering a CAGR of 6.4% from 2023 to 2030, according to a new report by Grand View Research, Inc.. Growing awareness about early diagnosis of chronic diseases and increasing demand for technologically advanced diagnostic equipment are some of the key factors anticipated to drive the market.
According to the estimates of Laboratory Economics, in 2012, over USD 20 billion was spent on laboratory mergers between 1996 and 2011. In 2011, approximately USD 3.5 billion was spent on laboratory mergers. Increasing worldwide geriatric population, growing healthcare expenditure, and rising patient awareness regarding early disease diagnosis are some of the key factors expected to propel the tissue diagnostics market. This, in turn, is likely to boost demand for tissue slicing equipment. However, reimbursement cuts and hospital consolidation are some of the factors expected to hamper growth.
Although the U.S. ranks first in terms of per capita healthcare spending, spending on clinical laboratories is significantly lower as compared to other healthcare aspects. Moreover, overall growth in the clinical laboratory market is majorly dependent on demographic factors, technological, medical, & scientific advancements, and disease burden specific to that region. Developed economies, such as the U.S., Germany, Japan, Canada, and France, have huge R&D budgets, higher technological advancements, and more awareness regarding various health aspects as compared to developing economies. This is likely to account for majority of the share in these regions.
Growing number of histopathology laboratories, high growth potential of anatomical pathology labs in emerging economies, and rising awareness regarding digital pathological systems are some key attributes that can provide new opportunities to players. Adoption rate of histology equipment is expected to gain substantial momentum owing to growing usage of technologically advanced biomarkers in diagnosing various diseases such as cancer and other infectious diseases.